Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Fortress Biotech (FBIO) over the last 4 years, with Dec 2024 value amounting to $20.8 million.

  • Fortress Biotech's Shares Outstanding (Diluted Average) rose 62.82% to $29.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $29.8 million, marking a year-over-year increase of 62.82%. This contributed to the annual value of $20.8 million for FY2024, which is 156.25% up from last year.
  • Latest data reveals that Fortress Biotech reported Shares Outstanding (Diluted Average) of $20.8 million as of FY2024, which was up 156.25% from $8.1 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Shares Outstanding (Diluted Average) registered a high of $81.7 million during FY2021, and its lowest value of $5.9 million during FY2022.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $11.6 million, with a median of $8.1 million in 2023.
  • Per our database at Business Quant, Fortress Biotech's Shares Outstanding (Diluted Average) slumped by 92.75% in 2022 and then soared by 156.25% in 2024.
  • Yearly analysis of 4 years shows Fortress Biotech's Shares Outstanding (Diluted Average) stood at $81.7 million in 2021, then crashed by 92.75% to $5.9 million in 2022, then soared by 36.89% to $8.1 million in 2023, then soared by 156.25% to $20.8 million in 2024.